Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors

International Journal of Radiation Oncology, Biology, Physics
Berrin PehlivanE B Hug

Abstract

Temporal lobe (TL) parenchyma toxicity constitutes one of the most frequent late adverse event in high-dose proton therapy (PT) for tumors of the skull base. We analyzed clinical events with dosimetric parameters in our patients treated for skull base tumors with spot-scanning PT. Between 1998 and 2005, a total of 62 patients received PT to a median dose of 71.7 Gy (relative biologic effectiveness [RBE]) (range, 63-74 Gy). The dose-volume histogram of each TL and the entire brain parenchyma (BP) were analyzed according to maximum, mean, and minimum dose as well as doses to 0.5, 1, 2, and 3 cc of brain volume (D(0.5), D(1), D(2), D(3)) and correlated with clinical events. Generalized equivalent uniform dose (gEUD) values were calculated. At a mean follow-up of 38 months (range, 14-92 months), 2 patients had developed symptomatic Grade 3 and 5 patients asymptomatic Grade 1 TL toxicity. Mean doses to a 2-cc volume of BP increased from 71 ± 5 Gy (RBE) for no toxicity to 74 ± 5 Gy (RBE) for Grade 1 and to 76 ± 2 Gy (RBE) for Grade 3 toxicity. TL events occurred in 6 of 7 patients (86%) at or above dose levels of ≥ 64 Gy (RBE) D(3), ≥ 68 Gy (RBE) D(2), ≥ 72 Gy (RBE) D(1), and ≥ 73 Gy (RBE) D(0.5), respectively (p = NS). No statistica...Continue Reading

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·M M UrieM Goitein
Jun 1, 1989·International Journal of Radiation Oncology, Biology, Physics·I L HabrandM Goitein
Dec 10, 1997·International Journal of Radiation Oncology, Biology, Physics·J DebusJ E Munzenrider
Apr 21, 1998·Seizure : the Journal of the British Epilepsy Association·S Baxendale
Jul 8, 1999·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·J E Munzenrider, N J Liebsch
Sep 2, 1999·Journal of Neurosurgery·E B HugJ M Slater
May 23, 2002·International Journal of Radiation Oncology, Biology, Physics·Harald PaganettiHerman D Suit
Nov 3, 2004·International Journal of Radiation Oncology, Biology, Physics·Hiroshi IgakiYasuyuki Akine
Mar 17, 2007·International Journal of Radiation Oncology, Biology, Physics·Daniela Schulz-ErtnerJürgen Debus
Apr 24, 2009·International Journal of Radiation Oncology, Biology, Physics·Carmen AresGudrun Goitein

❮ Previous
Next ❯

Citations

Mar 26, 2014·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Matthias UhlKlaus Herfarth
May 27, 2014·Neuro-Chirurgie·B GeorgeK Beccaria
Nov 19, 2013·Current Problems in Cancer·Virag DandekarPaul M Kent
Feb 1, 2015·International Journal of Radiation Oncology, Biology, Physics·Mark W McDonaldCynthia S J Calley
Oct 12, 2014·International Journal of Radiation Oncology, Biology, Physics·David R GrosshansAnita Mahajan
Jul 12, 2014·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ulrike MockBarbara Knäusl
Apr 26, 2019·Topics in Magnetic Resonance Imaging : TMRI·Christian D DiehlStephanie E Combs
Jul 3, 2019·The British Journal of Radiology·Robert PoelRobert Foerster
Mar 1, 2016·International Journal of Particle Therapy·Emma HollidaySteven J Frank
May 9, 2019·The British Journal of Radiology·Damien C WeberAlessia Pica
Apr 4, 2017·Current Treatment Options in Neurology·Stephanie E Combs
Mar 8, 2016·Journal of Neuro-oncology·Carmen AresDamien C Weber
Sep 19, 2019·Surgical Neurology International·Mohammed Alahmari, Yasin Temel
Jul 18, 2020·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Grete May EngesethGary Brandon Gunn
Jul 22, 2021·International Journal of Particle Therapy·Adam L HoltzmanWilliam M Mendenhall
Aug 31, 2021·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Magdalena GarbaczAntoni Rucinski
Nov 1, 2021·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·SungChul ParkTomoaki Okimoto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
Matthew KoshyBin S Teh
International Journal of Radiation Oncology, Biology, Physics
Jürgen DunstChristian Rübe
© 2022 Meta ULC. All rights reserved